Page 29 of 29 FirstFirst ... 19 27 28 29
Results 701 to 712 of 712

Thread: COVID-19 Novel Coronavirus pandemic

  1. #701
    Senior Member JohnLanders's Avatar
    Join Date
    May 2020
    Posts
    1,192
    Rep Power
    2130423
    Quote Originally Posted by KimTisha View Post
    Or my computer has it! I did a weird cross-post with JohnLanders today in the Glynda Evangalista thread, too.



    OMG, this makes perfect sense. Thank you. And along those lines, isn't COVID-19 a combo of SARS and Coronavirus? Maybe that's why they're coming up with this vaccine so quickly? We need JL to weigh in. He knows about this stuff.

    COVID-19 is actually related to MERS (Middle Eastern Respiratory Syndrome) and SARS (Severe Acute Respiratory Syndrome)

    You are right on this one

    https://www.niaid.nih.gov/diseases-conditions/covid-19

    In January 2020, a novel coronavirus, SARS-CoV-2, was identified as the cause of an outbreak of viral pneumonia in Wuhan, China. The disease, later named coronavirus disease 2019 (COVID-19), subsequently spread globally. In the first three months after COVID-19 emerged nearly 1 million people were infected and 50,000 died.

    The Centers for Disease Control and Prevention (CDC) developed a test to diagnose COVID-19 in respiratory and serum samples. NIAID also is accelerating efforts to develop additional diagnostic tests for COVID-19. These tests are helping facilitate preclinical studies and aid in the development of medical countermeasures.

    NIAID COVID-19 research efforts build on earlier research on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), which also are caused by coronaviruses. MERS is a viral respiratory disease that was first reported in Saudi Arabia in September 2012 and has since spread to 27 countries, according to the World Health Organization. Some people infected with MERS coronavirus (MERS-CoV) develop severe acute respiratory illness, including fever, cough, and shortness of breath. From its emergence through January 2020, WHO confirmed 2,519 MERS cases and 866 deaths (about 1 in 3). Among all reported cases in people, about 80% have occurred in Saudi Arabia. Only two people in the United States have tested positive for MERS-CoV, both of whom recovered. They were healthcare providers who lived in Saudi Arabia, where they likely were infected before traveling to the U.S., according to the CDC.

    Infection with SARS coronavirus (SARS-CoV) can cause a severe viral respiratory illness. SARS was first reported in Asia in February 2003, though cases subsequently were tracked to November 2002. SARS quickly spread to 26 countries before being contained after about four months. More than 8,000 people fell ill from SARS and 774 died. Since 2004, there have been no reported SARS cases.

    Research evidence suggests that SARS-CoV and MERS-CoV originated in bats, and it is likely that SARS-CoV-2 did as well. SARS-CoV then spread from infected civets to people, while MERS-CoV spreads from infected dromedary camels to people. Scientists are trying to determine how SARS-CoV-2 spread from an animal reservoir to people.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176926/

  2. #702
    Senior Member JohnLanders's Avatar
    Join Date
    May 2020
    Posts
    1,192
    Rep Power
    2130423
    https://ktla.com/news/local-news/tho...door-services/

    OK then

    In defiance of a restraining order, a Thousand Oaks pastor vowed to continue indoor Sunday services at a church that has faced legal action from Ventura County over violations of public health orders.

    The county has sued the Godspeak Calvary Chapel, arguing that it threatened public safety by repeatedly holding indoor services with more than 200 people. Officials also alleged that McCoy and other members have not worn masks and even sometimes “encouraged the violations” of the mandate.

    A court on Friday granted a temporary restraining order requiring the church and Pastor Rob McCoy to have religious services only outdoors, and with congregants wearing masks and practicing physical distancing, in compliance with guidelines meant to curb the spread of the coronavirus.

    But hours later, the pastor announced the church will defy the orders.

    “I wish you didn’t have to come to this, I really do. But we will be violating the judge’s order, we will be open this Sunday,” McCoy said in a video posted to social media. “Now, I don’t know what that means as far as who’s gonna stop us, but we’re planning on having services at 9, 11, and 1.”

    The pastor described the measures taken by the county as “draconian” and denied that the church has put anyone danger, saying there have been no COVID-19 cases at the church.

    “We’re going to keep worshiping God, if they seek to arrest me and the thousand of you, it’s almost like the first thousand get a prize: You get a citation. It’s a misdemeanor. You want to be one of the thousand? Come.”
    Related Content


    McCoy encouraged people to come out to the church Sunday, despite the judge’s orders.

    “I know that there’s gonna be a lot of people coming out, we’ve been getting calls from all over the country. My phone has never been this busy,” he said, also claiming to have received calls from the White House.

    The pastor said it’s “impossible” for the church to hold services at a park, adding “we’ve had threats here and protesters so our people would be in danger.”

    McCoy was a former Thousand Oaks mayor who resigned his post as City Council member on April 4 after Gov. Gavin Newsom declared churches nonessential, the Los Angeles Times reports.

    Ventura County has had 8,146 people test positive for the virus as of Friday, with 89 people who have succumbed to the illness. The county is one of 37 being monitored by the state for heightened coronavirus activity as its health officials grapple with increasing COVID-19 hospitalizations and cases that are, in part, being driven by virus transmission at gatherings and workplaces.

    In mid-July, Newsom told counties on the watchlist, which includes all counties in Southern California, to close indoor activities at places of worship, fitness centers, offices for non-critical sectors, personal care services, hair salons, barbershops, and indoor malls.

    The strict orders came as coronavirus cases surged statewide and hospitalization rates reached all-time highs.

    Ventura County leaders have approved the use of restraining orders and other enforcement actions against individuals and businesses that refuse to comply with local and state health orders in a bid to control the spread of the virus.

  3. #703

  4. #704
    Senior Member KimTisha's Avatar
    Join Date
    Jul 2006
    Location
    Somewhere Over the Rainbow
    Posts
    6,030
    Rep Power
    11213081
    MANHATTAN BEACH, Calif. - A bloody brawl broke out in Manhattan Beach after a couple confronted two men for not wearing masks, causing an argument that turned violent when the woman threw coffee into the face of one of the men.
    Geez, us Maskers are so morally superior, aren't we?

    I know RBW posted an article about an anti-masker who confronted a child, but the vast majority of these incidents are perpetrated by mask-wearing jackholes who use it as an excuse to vent their frustration on the public. IMHO, attacking someone for not wearing a mask is worse than not wearing a mask in the first place. One is an assumed threat, the other is actual violence.
    You are talking to a woman who has laughed in the face of death, sneered at doom and chuckled at catastrophe.
    ...Collector of Chairs. Reader of Books. Hater of Nutmeg...

  5. #705
    Senior Member JohnLanders's Avatar
    Join Date
    May 2020
    Posts
    1,192
    Rep Power
    2130423
    Quote Originally Posted by KimTisha View Post
    Geez, us Maskers are so morally superior, aren't we?

    I know RBW posted an article about an anti-masker who confronted a child, but the vast majority of these incidents are perpetrated by mask-wearing jackholes who use it as an excuse to vent their frustration on the public. IMHO, attacking someone for not wearing a mask is worse than not wearing a mask in the first place. One is an assumed threat, the other is actual violence.
    I swear to fucking god I am pro mask myself but I am not Morally superior. It sounds like Los Angeles has become the Florida of Pro-Mask People as in the recent SoCal Karen reports are showing.

    I swear I thought only Anti-Mask people were playing "Morally Superior" Card due to the trending Karen videos of people getting stopped by Supermarket staff members at the door because of state rules.

    Expect our side to get hijacked in the 2020 elections.

  6. #706
    Senior Member JohnLanders's Avatar
    Join Date
    May 2020
    Posts
    1,192
    Rep Power
    2130423
    https://www.reuters.com/article/us-h...-idUSKCN24T0YM



    TOKYO (Reuters) - Fujifilm Holdings Corp’s Avigan, once hyped as a potential COVID-19 treatment by Japan’s prime minister, is facing uncertain prospects in the country, dampened by disappointing clinical studies and slow progress in regulatory review.

    Shares of Fujifilm hit record highs in early April, fueled by optimism for the drug, but have since lost a quarter of their value, highlighting the risks of betting on experimental COVID-19 vaccines and treatments that are often politically promoted early in their development process.

    Prime Minister Shinzo Abe previously touted Avigan’s potential as Japan’s contribution to a global race for coronavirus treatments, aiming for domestic approval in May and offering to give it away to other countries. He mentioned the drug in at least 10 official speeches from February.

    But Abe has lately gone mum on the drug and regulatory deadlines have lapsed, while researchers at Fujita Health University said earlier this month that their Avigan study was inconclusive.

    “I think that does not look good for any early approval,” said one clinical trial expert, referring to the Fujita study, and asking not to be identified due to professional connections in Japan.

    Interest in Avigan, developed more than 20 years ago, soared in March after a Chinese official said it appeared to help patients recover from COVID-19. It is now the subject of at least 28 clinical trials around the world.

    Fujifilm has not yet submitted the drug for approval to Japanese authorities as a treatment for COVID-19, and has said it will take that step as soon as possible. Health ministry official Yasuyuki Sahara said the government stands ready to review Avigan once Fujifilm submits it for approval.

    The former chief of Japan’s main drug regulator, however, warned against a hasty approval of Avigan before its efficacy can be proven.

    ADVERTISEMENT


    “When it comes to regulatory bodies, trust is critically important,” said Tatsuya Kondo who ran the Pharmaceuticals and Medical Devices Agency for 11 years until 2019. “If they make an incomplete judgment, it could raise doubts about the whole process.”

    As the coronavirus pandemic rages on worldwide, though, some are still hopeful of positive outcomes of the Avigan trials.

    Tetsuya Nakamura, the lead researcher at Gunma University, which is running one of the two remaining trials on Avigan in Japan, told Reuters the university is “calmly advancing our research without pressure on the results,” as their study doesn’t rely on public funds.

    Fujifilm Toyama Chemical, the Avigan-manufacturing unit of Fujifilm whose own trial is still listed as recruiting patients, is working to complete phase III clinical trials as soon as possible, Fujifilm spokesman Shunsuke Saito said.

    The company is continuing with plans to boost Avigan production to 300,000 doses a month in line with a request from the government, he said.

    Stanford University is soon to start a phase II trial of 120 patients with mild symptoms and could move to a phase III around September, said Stanford professor Yvonne Maldonado.

    “We’re moving as fast as we can,” she said. If the drug can be shown to reduce symptoms and the viral load among patients, “that would be a big deal”.

    Although Avigan, generically known as favipiravir, has gone off patent in many markets, the brand and Fujifilm’s know-how in making it still have value. Earlier this month, Fujifilm sold off most overseas rights on Avigan to India’s Dr Reddy’s Laboratories.

    That deal involves a research partnership, and Japanese media reported that Dr Reddy’s will carry out a clinical trial of Avigan in Kuwait on behalf of Fujifilm.

    That data could possibly help Fujifilm build its regulatory case in Japan, said Credit Suisse analyst Fumiyoshi Sakai.

    “Probably it is too early to count out Avigan,” Sakai said.

  7. #707
    Senior Member JohnLanders's Avatar
    Join Date
    May 2020
    Posts
    1,192
    Rep Power
    2130423
    https://www.fiercepharma.com/manufac...-vaccine-trial

    Maryland biotech Novavax scored a big leg up in its hunt for a COVID-19 vaccine with a major infusion from the Trump administration this month. Now, Novavax is using some of those funds to help supply doses of its shot for a pivotal late-stage trial down the road.

    Fujifilm Diosynth Biotechnologies will churn out clinical supply for a phase 3 trial of Novavax's COVID-19 vaccine candidate expected to begin in the fall, according to a manufacturing pact signed Thursday.

    Fujifilm has already begun manufacturing bulk drug substance for the shot at its Morrisville, North Carolina, facility, the companies said in a joint release.

    The arrangement will be funded through a $1.6 billion grant from the Trump administration Warp Speed initiative, which aims to rapidly develop and distribute workable COVID-19 vaccines to U.S. patients. Novavax plans to use the government funding to finance a phase 3 involving up to 30,000 patients and rapidly scale manufacturing to produce 100 million doses of the shot by the end of 2020.

    The Fujifilm pact is the first Novavax has signed to make good on the Trump administration's down payment. Novavax is set to read out phase 1 clinical data for its vaccine within weeks and could roll into phase 2 testing immediately after that.

    The road to success for Novavax—a once-troubled biotech without an approved vaccine—could come with a big payday for its executives if its COVID-19 shot moves into the next phase of testing.

    Four Novavax executives, including CEO Stanley Erck, would together earn 830,000 stock options if the COVID-19 vaccine, dubbed NVX-CoV2373, simply enters phase 2 human testing by April 2021, according to a proxy filing.

    Those options are valued at roughly $100 million at Novavax's pumped-up stock price, which has skyrocketed in recent months as the biotech moves forward with its COVID-19 shot and a four-strain flu hopeful.

    Meanwhile, Fujifilm has been busy producing doses of flu drug Avigan as a potential therapy for COVID-19 alongside generics maker Dr. Reddy's Laboratories and Dubai-based Global Response Aid.

    Earlier this month, the partners struck a three-way deal to manufacture and sell Avigan, which at the time was already approved for COVID-19 in India and Russia. That agreement covered all countries other than Japan, China and Russia.

    For an unidentified lump-sum license fee and royalties on sales, Fujifilm granted Dr. Reddy’s and Global Response Aid access to Avigan’s preclinical and clinical data to help run their own studies. Dr. Reddy’s gained exclusive rights to the drug in India while Fujifilm transferred its manufacturing method exclusively to Dr. Reddy’s.

    Back in April, Fujifilm pledged to devote some of its manufacturing capacity in Denmark for a treatment yet to be identified by the Gates-funded COVID-19 Therapeutics Accelerator. As part of the deal, Fujifilm allocated space at its Hiller?d, Denmark, facility and said it would "work with a selected pharmaceutical partner in supporting the swift manufacture and dedicated supply for patients with COVID-19 in lower-income countries," the CDMO said in a release.

    https://www.fiercepharma.com/manufac...19-drug-avigan

    Meeting global demand for a potential COVID-19 treatment is more than any one company can handle on its own. Acknowledging that reality, Japanese drugmaker Fujifilm has picked partners for its offering.

    Fujifilm has struck a three-way deal with India’s Dr. Reddy’s Laboratories and Dubai-based Global Response Aid to manufacture and sell its flu drug Avigan (favipiravir) for potential treatment of COVID-19, the company said Wednesday.

    The drug is already approved for COVID-19 in India and Russia. The new agreement covers all countries other than Japan, China and Russia.

    Specifically, for an unidentified lump-sum license fee and royalties on sales, Fujifilm is granting Dr. Reddy’s and GRA access to Avigan’s preclinical and clinical data to help run their own studies. Dr. Reddy’s gains exclusive rights to the drug in India.

    In addition, Fujifilm will transfer its manufacturing method exclusively to Dr. Reddy’s, which will establish production of the drug and utilize GRA’s global sales network to supply the med.

    Avigan was originally developed against influenza pandemics. It gained global attention when Japanese Prime Minister Shinzo Abe touted it as a potential COVID-19 treatment.

    With that government support, a fast-track approval in Japan was initially expected in May. But clinical research on the drug suddenly slowed down as COVID-19 cases dropped in Japan. A month ago, Nikkei Asian Review reported that completion of the trial would instead come in July at the earliest, as it has only hit around 70% of the enrollment goal.

    Back in April, amid speculation around Avigan’s potential in COVID-19 and its side effects, including birth defects, Fujifilm said it would increase monthly production of Avigan up to 100,000 treatment courses by July, about 2.5 times more than its level at the beginning of March.

    On June 20, India’s Glenmark Pharmaceuticals won a local go-ahead to market a generic version of Avigan, which it’s selling under the brand FabiFlu, for the treatment of mild to moderate COVID-19 patients.

    Meanwhile, Gilead Sciences has also signed on multiple partners for FDA-authorized COVID-19 drug remdesivir, including India's Cipla and Hetero Labs and Jubilant Life Sciences.
    Thats right Fujifilm a former rival to Kodak is now investing in the biotech industry.

  8. #708
    Senior Member KimTisha's Avatar
    Join Date
    Jul 2006
    Location
    Somewhere Over the Rainbow
    Posts
    6,030
    Rep Power
    11213081
    Quote Originally Posted by JohnLanders View Post
    I swear to fucking god I am pro mask myself but I am not Morally superior. It sounds like Los Angeles has become the Florida of Pro-Mask People as in the recent SoCal Karen reports are showing.

    I swear I thought only Anti-Mask people were playing "Morally Superior" Card due to the trending Karen videos of people getting stopped by Supermarket staff members at the door because of state rules.

    Expect our side to get hijacked in the 2020 elections.
    Nah. Not only are we morally superior by virtue of the fact we wear masks in the first place, but we also get to declare moral superiority on mask content. Because some masks are morally objectionable. Yeah, the Maskers have morality all sewn up.

    And this is NOT a threadjack. We are discussing maskers versus anti-maskers in a COVID-19 thread. Perfectly acceptable.
    You are talking to a woman who has laughed in the face of death, sneered at doom and chuckled at catastrophe.
    ...Collector of Chairs. Reader of Books. Hater of Nutmeg...

  9. #709
    Senior Member JohnLanders's Avatar
    Join Date
    May 2020
    Posts
    1,192
    Rep Power
    2130423
    https://ktla.com/news/nationworld/ru...ic-skepticism/

    Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease because the shots have only been studied in dozens of people.

    President Vladimir Putin announced the Health Ministry’s approval and said one of his two adult daughters already was inoculated. He said the vaccine underwent the necessary tests and was shown to provide lasting immunity to the coronavirus, although Russian authorities have offered no proof to back up claims of safety or effectiveness.

    “I know it has proven efficient and forms a stable immunity,” Putin said. “We must be grateful to those who made that first step very important for our country and the entire world.”

    However, scientists in Russia and other countries sounded an alarm, saying that rushing to offer the vaccine before final-stage testing could backfire. What’s called a Phase 3 trial — which involves tens of thousands of people and can take months — is the only way to prove if an experimental vaccine is safe and really works.

    By comparison, vaccines entering final-stage testing in the U.S. require studies of 30,000 people each. Two vaccine candidates already have begun those huge studies, with three more set to get underway by fall.

    “Fast-tracked approval will not make Russia the leader in the race, it will just expose consumers of the vaccine to unnecessary danger,” said Russia’s Association of Clinical Trials Organizations, in urging government officials to postpone approving the vaccine without completed advanced trials.

    While Russian officials have said large-scale production of the vaccine wasn’t scheduled until September, Deputy Prime Minister Tatyana Golikova said vaccination of doctors could start as early as this month. Officials say they will be closely monitored after the injections. Mass vaccination may begin as early as October.

    “We expect tens of thousands of volunteers to be vaccinated within the next months,” Kirill Dmitriev, chief executive of the Russian Direct Investment Fund that bankrolled the vaccine, told reporters.

    The vaccine developed by the Gamaleya Institute in Moscow with assistance from Russia’s Defense Ministry uses a different virus — the common cold-causing adenovirus — that’s been modified to carry genes for the “spike” protein that coats the coronavirus, as a way to prime the body to recognize if a real COVID-19 infection comes along.

    That’s a similar technology as vaccines being developed by China’s CanSino Biologics and Britain’s Oxford University and AstraZeneca — but unlike those companies, Russian scientists haven’t published any scientific information about how the vaccine has performed in animal tests or in early-stage human studies.

    Dmitriev said even as Russian doctors and teachers start getting vaccinated, advanced trials are set to start Wednesday that will involve “several thousand people” and span several countries, including the United Arab Emirates, Saudi Arabia, the Philippines and possibly Brazil.

    The Associated Press couldn’t find documentation in the Russian Health Ministry’s records indicating that permission to start the advanced trials was granted. The ministry has not responded to a request for comment.

    Putin said one of his daughters has received two doses, and had minor side effects such as slight fever, and is now “feeling well and has a high number of antibodies.” It wasn’t clear if she was one of the study volunteers.

    The Health Ministry said in a statement Tuesday that the vaccine is expected to provide immunity from the coronavirus for up to two years, citing its experience with vaccines made with similar technology.

    However, scientists around the world have been cautioning that even if vaccine candidates are proven to work, it will take even more time to tell how long the protection will last.

    “The collateral damage from release of any vaccine that was less than safe and effective would exacerbate our current problems insurmountably,” Imperial College London immunology professor Danny Altmann said in a statement Tuesday.

    The World Health Organization said all vaccine candidates should go through full stages of testing before being rolled out. Experts have warned that vaccines that are not properly tested can cause harm in many ways — from harming health to creating a false sense of security or undermining trust in vaccinations.

    Becoming the first country in the world to approve a vaccine was a matter of national prestige for the Kremlin as it tries to assert the image of Russia as a global power. Putin repeatedly praised Russia’s effective response to the outbreak in televised addresses to the nation, while some of Moscow’s top officials – including the country’s prime minister and Putin’s own spokesperson – became infected.

    And the U.S., Britain and Canada last month accused Russia of using hackers to steal vaccine research from Western labs. Russia has denied involvement.

    Russia has so far registered 897,599 coronavirus cases, including 15,131 deaths.

    The Gamaleya Institute’s director, Alexander Gintsburg, raised eyebrows in May when he said that he and other researchers tried the vaccine on themselves before the start of human studies.

    Those trials started June 17 with 76 volunteers. Half were injected with a vaccine in liquid form and the other half with a vaccine that came as soluble powder. Some in the first group were recruited from the military, which raised concerns that servicemen may have been pressured to participate. The test was declared completed earlier this month.

    “It’s a too early stage to truly assess whether it’s going to be effective, whether it’s going to work or not,” Dr. Michael Head, senior research fellow in global health at the University of Southampton.

    It’s not Russia’s first controversial vaccine. Putin has bragged that Russian scientists delivered an Ebola vaccine that “proved to be the most effective in the world” and “made a real contribution to fighting the Ebola fever in Africa.” However, there is little evidence either of the two Ebola vaccines approved in Russia was widely used in Africa. As of 2019, both of those vaccines were listed by the WHO as “candidate vaccines.”

  10. #710

  11. #711
    Senior Member JohnLanders's Avatar
    Join Date
    May 2020
    Posts
    1,192
    Rep Power
    2130423
    https://www.hawaiinewsnow.com/2020/0...doubling-days/

    AP) - It took six months for the world to reach 10 million confirmed cases of the coronavirus. It took just over six weeks for that number to double.

    The worldwide count of known COVID-19 infections climbed past 20 million on Monday, with more than half of them from just three countries: the U.S., India and Brazil, according to the tally kept by Johns Hopkins University.

    The average number of new cases per day in the U.S. has declined in recent weeks but is still running high at over 54,000, versus almost 59,000 in India and nearly 44,000 in Brazil.

    In other developments Tuesday:

    — Russia became the first country to approve a vaccine against the virus. While a proven coronavirus vaccine would be an epic medical breakthrough, the move raised alarms among scientists because the shots have not been subjected to large-scale testing in humans. They have only been studied in dozens of people, not the thousands typically involved.

    — The Big Ten and Pac-12 announced they won’t play football this fall because of the virus, taking two of college sports’ five powerhouse conferences out of the season. The Big Ten includes Ohio State, Michigan, Nebraska and Penn State, while the Pac-12 includes Arizona, Arizona State, UCLA, the University of Southern California, Oregon, Utah and Washington. College football’s lack of centralized leadership leaves every conference to decide for itself.

    The severe and sustained crisis in the U.S. — over 5 million cases and 163,000 deaths, easily the highest totals of any country — has dismayed and surprised many around the world, given the nation’s vaunted scientific ingenuity and the head start it had over Europe and Asia to prepare.



    South Africa, Colombia, Mexico, Peru, Argentina, Russia and the Philippines round out the list of the top 10 countries contributing the most new cases to the global tally since July 22, according to an Associated Press analysis of Johns Hopkins data through Monday.

    The real number of people infected by the virus around the world is believed to be much higher — perhaps 10 times higher in the U.S., according to the Centers for Disease Control and Prevention — given testing limitations and the many mild cases that have gone unreported or unrecognized.

    Some of the worst-hit nations have been those whose leaders have downplayed the severity of COVID-19, undercut the advice of health experts and pushed unproven remedies.

    President Donald Trump, Brazil's President Jair Bolsonaro and Mexican President Andr?s Manuel L?pez Obrador, for example, all rarely wear masks and have resisted calls for strict lockdowns. Trump and Bolsonaro have promoted the anti-malaria drug hydroxychloroquine, even though studies have shown it to be useless against the virus, with potentially deadly side effects.

    In the U.S., Mexico and Brazil, testing has been criticized as inadequate. While the U.S. has ramped up testing in recent months, Americans have faced discouragingly long lines and delays in getting the results. In Mexico, 47% of tests are coming back positive, suggesting that only seriously ill people are getting screened.

    Contact tracing, which has helped authorities in other countries get a handle on the spread, has also been criticized as insufficient in all three countries.

    The U.S., with about 4% of the world’s population, accounts for about 25% of the known coronavirus infections and 22% of the deaths.



    Mexico has reported nearly 500,000 cases and more than 50,300 deaths, but the president’s point man on the epidemic, Assistant Health Secretary Hugo L?pez-Gatell, said a full lockdown would prove too costly for people with little savings and tenuous daily incomes.

    “We do not want a solution that would, in social terms, be more costly than the disease itself,” he said.

    Cases have begun to rise significantly in Caracas, Venezuela, perhaps one of the world’s least-prepared cities to face the pandemic.

    The country has been under a lockdown since March, but limited testing, open defiance of quarantine measures and the return of tens of thousands of Venezuelan migrants from countries with higher caseloads have resulted in a steady expansion that is starting to overwhelm hospitals with scarce supplies.

    “What has been successful in other countries is massive testing and isolating the population that is sick,” said Domingo Subero, 66, an engineer worried about the situation in Caracas. “Here, neither of those two things is happening.”

    Elsewhere around the world, New Zealand, which has been praised for quickly getting the virus under control, reported the first cases of local transmission in the country in 102 days. Prime Minister Jacinda Ardern said four cases were discovered in a single Auckland household.

  12. #712
    Senior Member JohnLanders's Avatar
    Join Date
    May 2020
    Posts
    1,192
    Rep Power
    2130423
    https://www.kron4.com/news/bay-area/...ight-covid-19/

    SAN FRANCISCO (KRON) – Researchers at the University of California, San Francisco say they have created a nasal spray that can help fight the coronavirus as anti-viral.

    “Far more effective than wearable forms of personal protective equipment, we think of AeroNabs as a molecular form of PPE that could serve as an important stopgap until vaccines provide a more permanent solution to COVID-19,” said AeroNabs co-inventor Peter Walter, professor of biochemistry and biophysics at UCSF, in a news release.

    According to co-inventor Aashish Manglik, MD, Ph.D., an assistant professor of pharmaceutical chemistry, nanobodies in the spray are smaller than human antibodies, which make them easier to manipulate in a laboratory setting

    Because of this, nanobodies are less expensive and easier to mass-produce.

    At this time, the researchers are currently working to get the spray manufactured and clinically tested.

Thread Information

Users Browsing this Thread

There are currently 2 users browsing this thread. (0 members and 2 guests)

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •